Head to head
Ivim Health vs MEDVi
What each one charges a month, which pharmacy each will name, and where each will treat you — read off their own sites, not their marketing.
Both sell compounded tirzepatide, where our ranking places Ivim Health at #102 and MEDVi at #105 — on the criteria we publish.
What each actually charges
A blank means that provider does not sell that compound at all. Prices are the real month-to-month figure, not a prepay or first-month rate.
| Compound |  | ME MEDVi |
|---|---|---|
| Tirzepatide | $133/mo+ | $199/mo |
| Semaglutide | $223.99/mo | $166/mo |
| Sermorelin | $204/mo | Doesn't sell it |
| NAD+ | $129 + $75/mo membership | Doesn't sell it |
| Pharmacy named | Not disclosed | Not disclosed |
Ivim Health checked August 2026; MEDVi checked August 2026.
Who each one suits
Good fit if you're comfortable with a membership-gated telehealth model and will read the small print for the required $74.99/mo fee before signing up, rather than budgeting off the $133/mo headline alone.
The catch: FDA issued Ivim a warning letter (MARCS-CMS 721816, February 20, 2026, Center for Drug Evaluation and Research), addressed to Ivim Services LLC dba Ivim at 4200 Regent Street, Suite 200, Columbus, OH 43219 — the identical address independently confirmed as Ivim's own BBB profile address (A+ rating, accredited since 2/28/2023). The letter states FDA reviewed ivimhealth.com in December 2025 and found the compounded semaglutide and tirzepatide products displayed on the site identify "Ivim" on the pictured label, "suggesting Ivim is the compounder of those drugs when in fact it is not" — misbranded under FDCA §§502(a) and 502(bb), the same single-issue template as the first of BluefitMD's two citations on this same roster, and the same disclosable-not-disqualifying shape as Strut Health's letter. Independent of the FDA letter, Ivim's own legal documents contradict each other about which state even has jurisdiction over the company: its Terms and Conditions states it is "registered in Michigan... registered office at 336 W 1st St Ste 113, Flint, MI 48502" and that the Terms are "governed by... the laws of the State of Michigan" (§18) — then, in the same document, states disputes are subject to "exclusive jurisdiction and venue in the state and federal courts located in Franklin County, Ohio" (Columbus, where the FDA letter and BBB profile both place it) and that arbitration "will be conducted in Franklin County, Ohio." Its separate Membership Agreement states Michigan law AND Michigan jurisdiction, but directs legal notices to "Ivim's Principal Mailing Address at 4200 Regent Street, Suite 200, Columbus, OH 43219" — the Ohio address. Three of Ivim's own documents name three different combinations of state and address for what is legally the same company.
Good fit if you want one company selling both compounded tirzepatide and compounded semaglutide, with a headline price for each published directly on its site.
The catch: FDA issued MEDVi, LLC a warning letter (MARCS-CMS 721455, February 20, 2026, Center for Drug Evaluation and Research) — the same date, office, and "identifies '[name]' on the pictured label, suggesting [name] is the compounder when in fact it is not" template already documented here for a peer provider, addressed to MEDVi's own registered Delaware corporate address. Separately, outside investigative journalism (Futurism; Drug Discovery Trends) previously reported that MEDVi's advertising used fabricated physician names in ad creative; a live check of MEDVi's current core site (2026-08-03) found no named, invented physicians anywhere on its site today, though this was not an exhaustive sweep of every historical ad. Neither finding disqualifies MEDVi on its own, but both are on the record here.
Where each one will treat you
Ivim Health
Not published. No state list and no "all 50 states" claim appears anywhere on the site's public pages (product pages, Terms and Conditions, Membership Agreement, Refund and Returns Policy, Privacy Policy, or HIPAA Notice) — a reader only reaches a location field after completing Ivim's full medical questionnaire.
MEDVi
No states-served list or exclusion list was found.
Ready to start with one?
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.